Prospective Control Study of Clinical Effectiveness of Prophylactic Antibiotics in Laparoscopic Cholecystectomy on Infection Rate
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: This study evaluated the effectiveness of prophylactic antibiotics in elective laparoscopic cholecystectomy (LCC) for thereduction of postoperative infection rate. Materials and Methods: Elective LCC was performed on 529 patients at Jeonbuk National University Hospital between April 2015and August 2017. A total of 509 patients were enrolled based on the inclusion criteria. This prospective study compared the resultsfor antibiotic group (AG) (n=249, cefotetan 1 g, 1 dose/prophylactic) and non-antibiotic group (NAG) (n=260). Results: There were no significant differences in clinical characteristics between the two groups: AG and NAG (p=0.580, 0.782, and0.325, respectively). Levels of C-reactive protein were higher in NAG compared to AG at postoperative day 2 (16.6±24.2 vs. 24.2±40.6; p=0.033). There were no significant differences in white blood cell counts and erythrocyte sedimentation rate. Fever≥38°C on postoperative day 2 occurred in 3 (1.2%) and 9 (3%) patients in AG and NAG, respectively. One patient in each grouphad subhepatic fluid collection by abdominal computed tomography, but there was no evidence of infection. Two patients inNAG (3%) had serous wound drainage on postoperative day 14. Conclusion: Our results showed no significant differences in patients receiving or not receiving prophylactic antibiotics duringLCC. Therefore, it is not necessary to use prophylactic antibiotics during elective LCC in patients who meet the inclusion criteria.
Abstract
Purpose: This study evaluated the effectiveness of prophylactic antibiotics in elective laparoscopic cholecystectomy (LCC) for thereduction of postoperative infection rate. Materials and Methods: Elective LCC was performed on 529 patients at Jeonbuk National University Hospital between April 2015and August 2017. A total of 509 patients were enrolled based on the inclusion criteria. This prospective study compared the resultsfor antibiotic group (AG) (n=249, cefotetan 1 g, 1 dose/prophylactic) and non-antibiotic group (NAG) (n=260). Results: There were no significant differences in clinical characteristics between the two groups: AG and NAG (p=0.580, 0.782, and0.325, respectively). Levels of C-reactive protein were higher in NAG compared to AG at postoperative day 2 (16.6±24.2 vs. 24.2±40.6; p=0.033). There were no significant differences in white blood cell counts and erythrocyte sedimentation rate. Fever≥38°C on postoperative day 2 occurred in 3 (1.2%) and 9 (3%) patients in AG and NAG, respectively. One patient in each grouphad subhepatic fluid collection by abdominal computed tomography, but there was no evidence of infection. Two patients inNAG (3%) had serous wound drainage on postoperative day 14. Conclusion: Our results showed no significant differences in patients receiving or not receiving prophylactic antibiotics duringLCC. Therefore, it is not necessary to use prophylactic antibiotics during elective LCC in patients who meet the inclusion criteria.
참고문헌 (18)
- Mangram AJ, "Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee", Infect Control Hosp Epidemiol, 20, pp.250~278 (1999)
- McGuckin M, "Infection and antimicrobial use in laparoscopic cholecystectomy", Infect Control Hosp Epidemiol, 20, pp.624~626 (1999)
- Catarci M, "Antibiotic prophylaxis in elective laparoscopic cholecystectomy. Lack of need or lack of evidence?", Surg Endosc, 18, pp.638~641 (2004)
- Choudhary A, "Role of prophylactic antibiotics in laparoscopic cholecystectomy : a metaanalysis", J Gastrointest Surg, 12, pp.1847~1853 (2008)
- Zhou H, "Meta-analysis : antibiotic prophylaxis in elective laparoscopic cholecystectomy", Aliment Pharmacol Ther, 29, pp.1086~1095 (2009)
- Sanabria A, "Antibiotic prophylaxis for patients undergoing elective laparoscopic cholecystectomy", Cochrane Database Syst Rev, pp.CD005265~ (2010)
- Yan RC, "The role of prophylactic antibiotics in laparoscopic cholecystectomy in preventing postoperative infection : a meta-analysis", J Laparoendosc Adv Surg Tech A, 21, pp.301~306 (2011)
- Pasquali S, "Meta-analysis of perioperative antibiotics in patients undergoing laparoscopic cholecystectomy", Br J Surg, 103, pp.27~34 (2016)
- Tocchi A, "The need for antibiotic prophylaxis in elective laparoscopic cholecystectomy : a prospective randomized study", Arch Surg, 135, pp.67~70 (2000)
- Mahatharadol V, "A reevaluation of antibiotic prophylaxis in laparoscopic cholecystectomy : a randomized controlled trial", J Med Assoc Thai, 84, pp.105~108 (2001)
- Koc M, "A prospective randomized study of prophylactic antibiotics in elective laparoscopic cholecystectomy", Surg Endosc, 17, pp.1716~1718 (2003)
- Liang B, "Safety and efficacy of antibiotic prophylaxis in patients undergoing elective laparoscopic cholecystectomy : a systematic review and meta-analysis", J Gastroenterol Hepatol, 31, pp.921~928 (2016)
- Targarona EM, "Single-dose antibiotic prophylaxis in patients at high risk for infection in biliary surgery : a prospective and randomized study comparing cefonicid with mezlocillin", Surgery, 107, pp.327~334 (1990)
- Nichols RL, "Preventing surgical site infections : a surgeon’s perspective", Emerg Infect Dis, 7, pp.220~224 (2001)
- Mangram AJ, "Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee", Infect Control Hosp Epidemiol, 20, pp.250~278 (1999)
- Leaper DJ, "A comparative trial between cefotetan and cephazolin for wound sepsis prophylaxis during elective upper gastrointestinal surgery with an investigation of cefotetan penetration into the obstructed biliary tree", J Hosp Infect, 7, pp.269~276 (1986)
- Chang WT, "Bacteriology and antimicrobial susceptibility in biliary tract disease : an audit of 10-year’s experience", Kaohsiung J Med Sci, 18, pp.221~228 (2002)
- Drumm J, "A comparison of cefotetan and cephazolin for prophylaxis against wound infection after elective cholecystectomy", J Hosp Infect, 6, pp.277~280 (1985)